CXC趋化因子受体7对缺血性脑卒中神经元细胞周期的影响
该研究在SH-SY5Y人神经母细胞瘤细胞中用小干扰RNA技术干扰CXCR7表达,构建氧糖剥夺/复氧(OGD/R)损伤模型,用流式细胞术检测CXCR7蛋白表达和细胞周期,用Western blotting检测CXCR7及Akt信号通路蛋白表达。结果:OGD/R 6小时后CXCR7表达较OGD/R 0小时显著下降,细胞周期阻滞于G0/G1期(均P<0.01);CXCR7 si-RNA干扰后再行OGD/R 6小时,与si-NC组比较CXCR7和磷酸化Akt表达显著下降,细胞周期阻滞于G0/G1期。作者认为CXCR7可能通过Akt信号通路调控缺血性脑卒中神经元细胞周期,对神经元细胞具有保护作用。
要点
- OGD/R 6小时较0小时:Western blotting检测CXCR7/GAPDH为0.483±0.098 vs. 1.000±0.000,流式细胞术为0.686±0.0524 vs. 1.000±0.000,均P<0.01。
- OGD/R 6小时较0小时细胞周期阻滞于G0/G1期(1.190±0.040 vs. 1.000±0.000,P<0.01)。
- CXCR7 si-RNA干扰后再行OGD/R 6小时,较si-NC组CXCR7/GAPDH为0.471±0.051 vs. 1.000±0.000(P<0.001)。
- 同条件下p-Akt/GAPDH为0.616±0.027 vs. 1.000±0.000(P<0.001),细胞周期阻滞于G0/G1期(1.105±0.033 vs. 1.000±0.000,P<0.05)。
- 作者认为CXCR7可能通过Akt信号通路调控缺血性脑卒中神经元细胞周期,对神经元细胞具有保护作用。
适用人群与场景
- 人神经母细胞瘤SH-SY5Y细胞,体外氧糖剥夺/复氧(OGD/R)损伤模型。
研究设计与关键结果
- 研究类型为体外细胞实验,在人神经母细胞瘤SH-SY5Y细胞中用小干扰RNA技术干扰CXCR7表达,构建OGD/R损伤模型,用流式细胞术检测CXCR7蛋白表达和细胞周期,用Western blotting检测CXCR7及Akt信号通路蛋白表达。
- OGD/R 6小时较OGD/R 0小时CXCR7表达显著下降:Western blotting检测CXCR7/GAPDH为0.483±0.098 vs. 1.000±0.000,流式细胞术为0.686±0.0524 vs. 1.000±0.000,均P<0.01;细胞周期阻滞于G0/G1期(1.190±0.040 vs. 1.000±0.000,P<0.01)。
- CXCR7 si-RNA干扰SH-SY5Y细胞后再行OGD/R 6小时,与同环境阴性对照组(si-NC组)比较,CXCR7表达显著下降(CXCR7/GAPDH:0.471±0.051 vs. 1.000±0.000,P<0.001),p-Akt表达显著下降(p-Akt/GAPDH:0.616±0.027 vs. 1.000±0.000,P<0.001),细胞周期阻滞于G0/G1期(1.105±0.033 vs. 1.000±0.000,P<0.05)。
证据类型、等级与局限
- 证据类型:体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文为体外细胞实验,结论为CXCR7可能通过Akt信号通路调控缺血性脑卒中神经元细胞周期,对神经元细胞具有保护作用,未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the function and mechanism of CXC chemokine receptor 7 (CXCR7) in neuronal cells of ischemic stroke.
METHODS: The expression of CXCR7 in human neuroblastoma SH-SY5Y cells was interfered by small interfering RNA (si-RNA) technique. Oxygen-glucose deprivation/reoxygenation (OGD/R) injury model was constructed in SH-SY5Y cells. CXCR7 protein expression and cell cycle were detected by flow cytometry (FCM). The protein expression of CXCR7 and Akt signaling pathway was detected by Western blotting.
RESULTS: After 6 hours of OGD/R, the expression of CXCR7 was significantly decreased compared with OGD/R 0 hour (CXCR7/GAPDH: 0.483±0.098 vs. 1.000±0.000 by Western blotting and 0.686±0.0524 vs. 1.000±0.000 by FCM, both P < 0.01), cell cycle arrest in G0/G1 phase (1.190±0.040 vs. 1.000±0.000, P < 0.01). After CXCR7 si-RNA interference with SH-SY5Y cells, OGD/R was constructed again for 6 hours. Compared with negative control group (si-NC group) under the same environment, the expression of CXCR7 and phosphorylated Akt (p-Akt) was significantly decreased (CXCR7/GAPDH: 0.471±0.051 vs. 1.000±0.000, p-Akt/GAPDH: 0.616±0.027 vs. 1.000±0.000, both P < 0.001) and cell cycle arrest in G0/G1 phase (1.105±0.033 vs. 1.000±0.000, P < 0.05).
CONCLUSIONS: The CXCR7 could regulate the cycle of neuronal cells in ischemic stroke through Akt signaling pathway, which has a protective effect on neuronal cells.
参考来源
- Wang X, Meng H, Wang S, et al. [Effect of CXC chemokine receptor 7 on cell cycle of neuronal cells in ischemic stroke]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35387720. doi:10.3760/cma.j.cn121430-20211221-01898
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。